Apimeds Pharmaceuticals US, Inc. (APUS)

APUS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.64	0	0.41	0.01	0.17
Short-Term Investments	2	-	-	-	-
Cash & Short-Term Investments	3.64	0	0.41	0.01	0.17
Cash Growth	105157.89%	-99.16%	6551.77%	-96.40%	-
Other Current Assets	10.35	0.01	0.01	-	0
Total Current Assets	13.98	0.01	0.42	0.01	0.17
Net Property, Plant & Equipment	0.24	-	-	-	-
Other Long-Term Assets	149.96	-	-	-	-
Total Assets	164.18	0.01	0.42	0.01	0.17
Accounts Payable	0.92	0.59	0.05	0.04	0.01
Accrued Expenses	0.53	0.11	0.07	-	-
Short-Term Debt	0.51	0.33	-	0.28	-
Current Portion of Long-Term Debt	7.09	-	-	-	-
Current Portion of Leases	0.04	-	-	-	-
Other Current Liabilities	1.62	-	-	-	-
Total Current Liabilities	10.71	1.02	0.12	0.32	0.01
Long-Term Debt	-	0.35	0.27	0.4	0.4
Long-Term Leases	0.13	-	-	-	-
Total Long-Term Liabilities	0.13	0.35	0.27	0.4	0.4
Total Liabilities	10.84	1.37	0.39	0.72	0.41
Common Stock	0.13	0.08	0.08	0.1	0.1
Additional Paid-in Capital	163.54	2.95	2.95	1.41	1.22
Retained Earnings	-10.39	-4.39	-3	-2.22	-1.56
Total Common Shareholders' Equity	153.27	-1.36	0.03	-0.71	-0.24
Shareholders' Equity	153.35	-1.36	0.03	-0.71	-0.24
Total Liabilities & Equity	164.18	0.01	0.42	0.01	0.17
Total Debt	7.77	0.67	0.27	0.68	0.4
Net Cash (Debt)	-4.14	-0.67	0.14	-0.68	-0.23
Net Cash Per Share	-0.38	-0.09	0.03	-0.18	-0.06
Book Value	153.27	-1.36	0.03	-0.71	-0.24
Book Value Per Share	14.09	-0.17	0.01	-0.19	-0.06
Tangible Book Value	153.27	-1.36	0.03	-0.71	-0.24
Tangible Book Value Per Share	14.09	-0.17	0.01	-0.19	-0.06

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q